Skup podataka sa Zenodo · Murugan, Vel
Data from: Serosurvey of SARS-COV-2 at a large public university
- Licenca
- CC0 1.0dozvoljena komercijalna upotrebaTekst licence
- Licenca dozvoljava komercijalnu upotrebu. Obično treba navesti autora — tačni uslovi su u tekstu licence.
- Formati
- XLSX, MD
- Veličina
- 154 kB
- Ažurirano
- 13. 7. 2023.
Opis
Objective : This study investigated the seroprevalence of SARS-CoV-2 antibodies among adults over 18 years. Design : Prospective cohort study. Settings : a population-based study among the big university community. Participants : This study took volunteers over five days and recruited adult 1064 participants. Primary outcome measures : We conducted a seroprevalence in our community with SARS-CoV-2-specific antibodies due to previous exposure to SARS-CoV-2 and/or vaccination. Results : The seroprevalence of the anti-receptor binding domain (RBD) antibody was 90% by a lateral flow assay and 88% by a semi-quantitative chemiluminescent immunoassay. The seroprevalence for anti-nucleocapsid (NC) was 20%. In addition, individuals with previous natural COVID infection plus vaccination had higher anti-RBD antibody levels compared to those who had vaccination only or infection only. Individuals who had a breakthrough infection had the highest anti-RBD antibody levels. Conclusion : Accurate estimates of the cumulative incidence of SARS-CoV-2 infection can inform the development of university risk mitigation protocols such as encouraging booster shots, extending mask mandates, or reverting to…
Opis sa Zenodo, skraćen.
Fajlovi (2)
DataHunter ne čuva i ne deli ove fajlove: svaki link vodi do izvornog sajta. Pre upotrebe tamo proverite licencu.